AmDerma, Oculus deal

Oculus granted AmDerma exclusive rights to develop and commercialize compounds

Read the full 109 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE